EYE TUMOR RESEARCH FOUNDATION INC (EIN 232570195) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1989

Legal Domicile

Principal Officer

CAROL SHIELDS

Phone

2159283438

Tax Period

2023-01-01 to 2023-12-31

EYE TUMOR RESEARCH FOUNDATION INC, founded in 1989, is a small nonprofit that reported $153K in total revenue in fiscal year 2023. Revenue surged 36% from the prior year, signaling strong growth momentum. Expenses of $208K exceeded revenue, resulting in a 36% operating deficit.

Mission

THE FOUNDATION SEEKS CONTRIBUTIONS IN SUPPORT OF RESEARCH PROJECTS DESIGNED TO ACCUMULATE AND EVALUATE CLINICAL AND DEMOGRAPHIC DATA RELATIVE TO THE TREATMENT OF MALIGNANT MELANOMA AND RETINOBLASTOMA TUMORS OF THE EYE. THE FOCUS OF THE RESEARCH, SPONSORED BY THE FOUNDATION, IS TO ENHANCE TREATMENT METHODS, VISUAL RESULTS, AND MORTALITY RATES. IN ADDITION, THE FOUNDATION ACTIVELY PUBLISHES AND PRESENTS THE RESULTS OF SUCH RESEARCH FOR THE BENEFIT OF THE MEDICAL COMMUNICTY, WORLDWIDE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $146,726

Program Service Revenue $0

Investment Income $5,939

Other Revenue $0

TOTAL REVENUE $152,665

Expense Breakdown

Grants Paid $0

Salaries & Benefits $52,753

Fundraising Expenses $8,419

Program Expenses $197,002

Other Expenses $155,623

TOTAL EXPENSES $208,376

Year-over-Year Comparison

	2023	2022	Change
Revenue	$152,665	$112,489	+0.4%
Expenses	$208,376	$165,556	+0.3%
Net Income	$-55,711	$-53,067	+0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JERRY SHIELDS MD	PRESIDENT	5.00	Officer Director	$0	$0	$0
CAROL SHIELDS MD	VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
STEPHEN ROSS GREEN	SECRETARY	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$152,665	$208,376	$873,806	$-55,711
2022	$112,489	$165,556	$862,636	$-53,067
2021	$203,641	$127,119	$981,796	$76,522
2020	$171,343	$117,194	$898,064	$54,149
2019	$146,745	$108,110	$842,423	$38,635
2018	$137,438	$98,713	$787,485	$38,725

EYE TUMOR RESEARCH FOUNDATION INC